Silvio Napoli - 15 Apr 2026 Form 4 Insider Report for Lucid Group, Inc. (LCID)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Apr 2026, 16:12:45 UTC
Prior SEC filing
07 May 2025
Next SEC filing
08 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Bruce Wang, as attorney-in-fact for Silvio Napoli

Key filing fact

Silvio Napoli filed Form 4 for Lucid Group, Inc. (LCID) on 17 Apr 2026.

Key facts

  • This page summarizes Silvio Napoli's Form 4 filing for Lucid Group, Inc. (LCID).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 17 Apr 2026, 16:12.

Change

  • Previous filing in this sequence was filed on 07 May 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001783757 Primary reporting owner

Napoli Silvio

Relationship
Director
Address
C/O LUCID GROUP, INC., 7373 GATEWAY BOULEVARD, NEWARK
Signature
/s/ Bruce Wang, as attorney-in-fact for Silvio Napoli
Signature date
17 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LCID transaction

Class A Common Stock

Award

Transaction value
Shares
+402,073
Change %
Price
$0.000000*
Shares after
402,073
Date
15 Apr 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LCID transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares
+1,000,000
Change %
Price
$0.000000*
Shares after
0
Date
15 Apr 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
1,000,000
Exercise price
$8.21
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted stock units that will vest over four years, with 1/4th vesting on June 5, 2027 and 1/16th vesting quarterly thereafter in twelve installments, on each March 5, June 5, September 5, and December 5 of each calendar year that occurs following June 5, 2027, subject to the reporting person's continued employment with the Issuer or its subsidiary through each vesting date.

Footnote F2

Represents performance-based stock options that are divided into five tranches and subject to both time-based and performance-based vesting conditions. A given tranche vests upon the later of (x) the tranche's time-based vesting date (which is April 15, 2028 for tranche 1, April 15, 2029 for tranches 2 and 3 and April 15, 2030 for tranches 4 and 5) and (y) certification of achievement of the market capitalization performance hurdle applicable to the tranche ($5.0 billion, $7.5 billion, $10.0 billion, $12.5 billion, and $17.5 billion for tranches 1,2,3,4, and 5 respectively, calculated in accordance with the reporting person's stock option agreement), in each case, subject to the reporting person's continued employment with the Issuer or its subsidiary through each vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .